The right treatment at the right time
Postpartum depression (PPD) is a serious condition with documented negative and potentially tragic consequences, including risk of suicide, self-harm and recurrence. Prevalence of PPD ranges substantially from 1% to 13%, or even higher depending on case definition criteria, and risk factors include past history of depression, and pregnancy and birth complications. In an ideal world, PPDs should and would be prevented, and interventions to do this have been recognized. However, screening all women may come with adverse effects and not capture all those affected – it is a challenging discussion how to organise the best screening program for PPD.
Trine Munk-Olsen will present her work on efforts towards identifying mothers at particular high risk of postpartum depression and share her thoughts on challenges we face before screening efforts can be personalized, and how we best help women with mental health problems in pregnancy and postpartum, as this group is particularly vulnerable and at high risk of adverse outcomes.